USC forward Sam Dhillon is like most student-athletes. He spends much of his time away from the court in class or studying, and he doesn't get much sleep.
However, Dhillon is unlike his peers in so many more ways. The 6-8 junior is CEO and of an investment firm that's worth more than $3 million and is set to nearly triple its value next year. Oh, yeah, and he's also researching a cure for Alzheimer's Disease. ABC-7 in Los Angeles profiled the walk-on earlier this week.
The human biology major's company, Quest Investment Firm, was founded three years ago after he graduated valedictorian of Sacramento's Inderkum High School.